CONSORTIUM OF BIFIDOBACTERIA BIFIDOBACTERIUM BIFIDUM 791-MB, BIFIDOBACTERIUM LONGUM B 379M-MB, BIFIDOBACTERIUM ADOLESCENTIS G 7513-MB, BIFIDOBACTERIUM INFANTIS 73-15-MB, BIFIDOBACTERIUM BREVE 79-119-MB USED FOR PREPARING SOUR MILK, NONFERMENTED PRODUCTS, BIOLOGICALLY-ACTIVE ADDITIVES, BIFIDO-CONTAINING PREPARATIONS, COSMETIC AND HYGIENE AGENTS

摘要

The invention relates to biotechnology, in particular, to consortium of bifidobacteria strains, which can be used for preparing of different forms of bacterial preparations, preparations-probiotics based thereon, functional food products, biologically-active additives, nonfermented products, sour milk products, cosmetic and hygiene agents. The following bifidibacteria strains are used to prepare the consortium: Bifidobacterium bifidum 791-MB, Bifidobacterium longum b 379M-MB, Bifidobacterium adolescentis G 75130-MB, Bifidobacterium infantis 73-15-MB, Bifidobacterium breve 79-119-MB, the typical feature of which is high antibiotic and superoxide dismutase activity with expressed anti-oxidant activity. The superoxide dismutase activity of the consortium is at least 24.9 unit/mg protein of microbial mass. Exhibited specific activity, ability to utilizing a wide range of amino acids, high antibiotic-stability permitted to increase the consortium stability to damaging factors of aggressive medium of gastrointestinal tract during passing bifidobacteria in the gastrointestinal tract and thus increasing its colonizing activity.